Wockhardt receives US FDA approval for Clarithromycin tabs (PharmaBiz)
Wockhardt Ltd received approval from the US FDA for marketing Clarithromycin tablets in the US market. Its US subsidiary, Wockhardt USA Inc., is expected to launch the broad-spectrum macrolide antibiotic within the next two weeks.

US FDA approves Zydus Cadila's Warfarin tabs (PharmaBiz)
Cadila Healthcare Ltd has received approval from the US FDA to market Warfarin tablets in different strengths of 1 mg, 2 mg, 2.5 mg, 3 mg, 4mg, 5mg 6mg, 7.5 mg and 10 mg.